Introduction
Patients with obstructive sleep apnoea (OSA), treated by continuous positive air pressure (CPAP), have a level of driving performance that is comparable with that of controls [1] and, in many countries, are permitted to drive once successfully treated. However, polysomnographic studies have shown that withdrawal of CPAP in compliant users even for one night results in resumption of sleep disordered breathing, followed by immediate recovery on restarting treatment [2, 3] . Despite knowing the importance of treatment, even the most compliant CPAP users report occasionally missing treatment for one night, stating reasons such as 'have a cold' or 'away from home and unable to take the machine'. Few studies have assessed this temporary effect on driving ability.
For safety reasons, no real road driving studies have assessed this effect of CPAP withdrawal, and with the few driving simulation studies, only simple simulators have been utilised. These lack realism, typically using a replica steering wheel linked to a computer-based tracking task displayed on a computer screen. Using such a task, Turkington et al. [4] reported impaired tracking ability following CPAP withdrawal, although performance did not fall as low as pre-treatment levels. However, the test only lasted 20 min, which is too short a duration to reveal the full effect of sleepiness, and does not typify many driving situations, especially as sleepiness only becomes particu-larly evident during monotonous drives beyond 20 min (e.g. [5, 6] ). Moreover, realistic full-scale interactive driving simulators involving an interactive real car further add to the realism and, arguably, provide more valid data.
Although some laboratory studies have utilised simple performance measures, such as the PVT, in assessing acute CPAP withdrawal effects (e.g. [3, 7] ), such tests only last around 10 min and are of limited comparability with much longer and more realistic periods of driving. Similarly, whilst sleep onset findings with the multiple sleep latency test show significant reductions after one night of CPAP withdrawal (e.g. [8] ), this test involves participants lying down in a darkened room and encouraged to go to sleep, which clearly contrasts with the driver who has to stay awake under somewhat more stimulating conditions.
The present study had two aims. First is to assess the extent to which sustained driving performance in a full-size interactive and realistic driving simulator can be maintained following one night of CPAP withdrawal in otherwise successfully treated participants having OSA. The second aim comes from evidence that sufferers with OSA may have a distorted self-awareness of sleepiness when driving, at least before treatment [9] . In the light of this, a novel aspect of this study is to determine the extent to which those who have been successfully treated by CPAP might underestimate sleepiness whilst driving, following a night without CPAP.
Method
Participants OSA participants were recruited from a regional sleep apnoea patients association, all of whom had been undergoing CPAP treatment for an average of 7.8 years. All were men aged between 50 and 75 years, had Epworth sleepiness scale [10] scores <10 and drove >3 h per week. Initial selection was by structured interview, including questions relating to health, medication, sleep, driving and OSA, as well as caffeine intake. This was followed by measurements of height, weight and percentage body fat calculated using a body composition analyzer TBF-300 (TANITA Corporation). They were then given a familiarisation drive. This study was part of a larger investigation involving sleep restriction in patients and healthy controls [11] . Participants were asked if they would also be prepared to go without CPAP for another night so that we could make further comparisons. Eleven agreed to participate in this component of the study. Further details of these 11 participants can be seen in Table 1 . For all experimental phases (see below), participants were collected from and returned to home via taxi and advised not to drive or undertake any potentially hazardous activities until they had a full night's sleep with CPAP. They were given a small cash gift on completion. The study met with the full approval of the University's Ethical Committee.
Design and procedure
The study consisted of two conditions:
A normal night's sleep with CPAP 2. A night's sleep without CPAP
To ensure compliance with sleep instructions, participants wore wrist actimeters (Cambridge Neurotechnology, UK) for three nights prior to each experimental day, when they also kept daily logs of estimated sleep onset, and morning wakening and rising times. As well as sleep duration, sleep quality was assessed by calculating sleep disturbance index (SDI) SDI ¼ actual awake time min ð Þ=assumed total sleep min ð Þ
No alcohol was consumed 36 h prior to each drive and nil caffeine after 1800 hours the evening before. Participants refrained from eating after 1000 hours on the morning of the drive and had consumed only a light breakfast. On arrival at the laboratory, at 1300 hours, they were given a light lunch of two cheese rolls and a glass of water. Actimeters were downloaded to verify that they had complied with the previous night's sleep requirements. At 1315 hours, electrodes were applied, and they went to the simulator (see below) at 1350 hours, to be given 10 min to settle into the car, and the 2-h drive began at 1400 hours. Participants were instructed to drive in the left hand lane (as for UK roads), unless overtaking, at a speed appropriate for the road and where full control of the vehicle could be maintained. During the drive, the investigator remained in the room, out of sight, but there was no communication once the drive had begun. 
Subjective sleepiness
Every 200 s during the drive, participants were verbally prompted by the computer system to report their subjective sleepiness, and their numerical response was based on the nine-point Karolinska sleepiness scale (KSS): 1=extremely alert, 2=very alert, 3=alert, 4= rather alert, 5=neither alert nor sleepy, 6=some signs of sleepiness, 7=sleepy, no effort to stay awake, 8=sleepy, some effort to stay awake and 9=very sleepy, great effort to keep awake, fighting sleep. The scale was located on the car's dashboard and continuously visible to the driver. This prompting and its response quickly became routine for the driver.
EEG and EOG
Electrodes were attached for two channels of EEG, with inter-electrode distances carefully maintained by using the '10-20 EEG montage' (main channel C 3 -A 1 , backup channel C 4 -A 2 ), and there were two EOG channels (electrodes 1 cm lateral to and below left outer canthus and 1 cm lateral to and above right outer canthus; both referred to the centre of the forehead). EEGs and EOGs were recorded using 'Embla' (Flaga Medica Devices, Iceland) and spectrally analysed using 'Somnologica' (Flaga) in 4-s epochs. EEG low and high band-pass filtering at >20 and <4 Hz removed slow eye movements and muscle artefacts. In these circumstances, greater EEG power in the alpha (8-11 Hz) and theta (4-7 Hz) ranges reflect increased sleepiness [12] [13] [14] , whereas increased beta activity (13-20 Hz) indicates increased arousal, anxiety and mental effort, suggestive of trying to stay awake [15] [16] [17] . EEG power in 4-11 Hz (theta + alpha) was averaged in 1-min epochs, as was beta activity (13-20 Hz). To accommodate for individual differences in EEG power, and to allow comparisons between conditions, each individual's power in these ranges was standardised for each condition, by taking the difference between each minute's epoch and the individual's mean value over the first 30 min of the normal sleep with CPAP condition and then dividing this by the standard deviation around the mean of that 30 min of data [18] . This can mean that when 4-11 Hz power is particularly low, values may appear to be negative (as was the case with initial driving after normal sleep-see Figs. 4 and 6).
Statistical analyses
Repeated measures ANOVA were utilised, with two within-subject factors: condition (two levels: normal sleep and CPAP withdrawal) and duration of driving (four levels: 0-30, 30-60, 60-90 and 90-120 min). Where appropriate, square root transformations corrected for skewed driving incident raw data. Repeated measures t tests were applied to other overall group differences.
Results

Total sleep time and SDI
There was no significant difference between sleep duration between the two conditions. Withdrawal of CPAP significantly increased SDI from 7.9 after a normal night's sleep to 13.8 without CPAP [t(10)=3. (Fig. 3) . The interaction between condition and drive duration was also significant [F(3,30)=5.03, p<0.05], with CPAP withdrawal having a greater effect during the first hour.
EEG-theta + alpha power (mean values per minute)
There was no significant difference between conditions when data were collapsed into 30-min epochs [F(1,10)= 1.82, p=0.207], but there was a significant overall effect of drive duration [F(3.30)=6.03, p<0.05] (Fig. 4) . Interestingly, though, just before the mean onset of the first driving incident under CPAP withdrawal, between 45 and 50 min, there was a surge in this power compared with normal sleep; a one-tail t test [t(10)=1.87, p<0.05].
EEG-beta power (mean values per min)
When data were collapsed into 30-min epochs, there was a significance between conditions effect [F(1,10) = 4.0, p=0.05] indicating that participants were applying more compensatory effort after CPAP withdrawal (Fig. 5) . There was also an overall significant effect of drive duration [F(3,30)=3.56, p<0.05], but no significant interaction.
Correlation between theta + alpha power and KSS Figure 6 makes the direct comparison for CPAP withdrawal, and when these EEG data are collapsed into 200-s epochs and correlated with KSS data, the outcome was indeed highly significant [r=0.88, df=34; p<0.000], and likewise for the normal sleep condition [r=0.87, df=34; p<0.000].
Discussion
Our participants experienced significantly more sleep disturbance during CPAP withdrawal, despite a comparable Fig. 2 Number of minutes until first driving incident-mean and standard error. There was a significant between conditions effect Fig. 1 Driving incidents in 30 min epochs-mean and standard error. There was a significant between conditions effect total sleep times. This indicates a resumption of sleep disordered breathing, a finding in line with those from CPAP withdrawal studies using full PSG recordings [2, 3] .
ant CPAP users. A significant reduction (by 40 min) in 'safe driving time' was also evident after CPAP withdrawal, with the first incident being portended by a marked rise in alpha + theta activity 5 min beforehand. However, participants remained subjectively quite aware of their increased sleepiness (as determined objectively by EEG). Moreover, under both sleep conditions, there was a highly significant association between these two measures of sleepiness. This level of self-awareness of increasing sleepiness when driving is similar to what we have found with a group of healthy drivers of a similar age (mean age, 66.6 years [52-74 years]) having undergone sleep restriction [11] and in young male adult drivers [19, 20] . The incidents occurring on the simulator are indicative of dangerous driving, which is not to say that a collision is imminent or that an incident would occur at this time on a real road, as the more evident dangers of real driving would probably have enabled our participants to have driven safely for longer on real roads. Nevertheless, there is good evidence that simulators such as ours do reflect real driving conditions [21] , and it remains likely that following CPAP One night without CPAP significantly worsened sleepiness and driving performance in long-term treated compliwithdrawal driving performance would be impaired because of the obvious increase in daytime sleepiness.
Our study has shortcomings especially as participant selection may have been biased, as they were also selfselected from the original group of 19. All of the latter had been asked if they had ever missed a nights treatment, and all those reporting 'yes' to this question happened to decline to participate in this extra component of CPAP withdrawal and were absent from the 11 volunteers. It is a reoccurring problem in this type of study, as Yang et al. [2] noted "individuals who are compliant CPAP users may be reluctant to volunteer for this type of research if they have previously experienced marked negative symptoms with CPAP withdrawal." The withdrawal of the CPAP treatment may have influenced the participant's subjective reports of sleepiness. An alternative approach would have been to provide sham (non-therapeutic) CPAP so that participants would not be aware that they had not received treatment that night. However, such an addition may not have been allowed for ethical reasons. The current protocol was designed to represent occasions when patients may miss a nights treatment due to reasons such as being away from home and not taking the machine with them, on such occasions patients would be aware that they had not used Fig. 5 Mean standardised beta (13-20 Hz) EEG power in 1-min epochs (smoothed by three-point running average). There was a significance between conditions effect with more beta power following CPAP withdrawal Fig. 6 Comparison of KSS with standardised EEG theta + alpha following CPAP withdrawal. The two measures are significantly correlated the treatment and as such withdrawal of treatment in our study allows us to assess the impact this would have.
Ours was a study designed to highlight the risk of missing one night's CPAP treatment in compliant users. However, many OSA patients use their CPAP for only part of a night, and we have yet to determine to what extent this might impact on driving ability.
OSA patients need to know that even if they are generally fully compliant with treatment, CPAP withdrawal is likely to increase sleepiness and impair driving to a greater degree than might be anticipated, especially on monotonous roads and during the afternoon bi-circadian trough.
